Clinical Trial Update: Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants [Phase 3]

View source ↗

Summary

Phase 3 trial results for alisporivir-based triple therapy in treatment-naïve chronic hepatitis C genotype 1 patients have been completed. Results on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alisporivir (alisporivir)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2016-09-30